Professional Documents
Culture Documents
Week 4 LO Tristan
Week 4 LO Tristan
Weekly Objectives
1. List the major air pollutants and the factors which influences deposition of pollutants within the respiratory
system (particles, ozone, oxides of nitrogen, sulfur oxides, environmental tobacco smoke, radon organic dusts,
metal fumes)
Dust from such things as wood, coal, asbestos, silica and talc. Dust from cereal grains, coffee, pesticides, drugs or
enzyme powders, metals and fiberglass can also do damage to the lungs.
Fumes from metal that are heated and cooled quickly. This process results in fine, solid particles to be released into
the air. Example of jobs that expose workers to these types of fumes includes, welding (pengelasan),
smelting(peleburan), furnace work, pottery making, plastic manufacture and rubber operations.
Smoke from burning organic materials. Smoke contains a variety of particles, gases and vapors depending on what
substance is being burned. These particles, gases and vapors if inhaled, can damage the lungs. Firefighters are at an
increased risk.
Gases such as Formaldehyde, Ammonia, Chlorine, Sulfur dioxide, Ozone and Nitrogen oxides. These gases are
associated with jobs involving chemical reactions and jobs that require high heat (e.g welding, smelting, oven drying
and furnace work).
Vapors are gas forms of liquids that can revert back to liquid forms with particular temperature or pressure. Vapors
given off by solvents usually irritate the nose and throat first before affecting the lungs.
Mists or sprays from paints, lacquers (e.g varnish), hair spray, pesticides, cleaning products, acids, oils and solvents
(e.g turpentine)
3. Describe the macroscopic and microscopic pathology of the major types of lung and pleural cancers-squamous,
adenocarcinoma, large cell, small cell carcinoma and pleural mesothelioma.
4. Recognize the clinical therapeutic implications of small cell carcinoma and non-small cell carcinoma (SSC and
NSSC)
5. Describe the clinical procedures to get cells and tissues for the diagnosis of lung cancer
Your doctor puts a flexible tube that's about as wide as a pencil into your mouth or nose, and from there into your lungs. A
light and camera help guide tiny tools that take cells from your lung out through the tube. You'll be awake while this is going
on, but you may get medication through an IV to help you to relax, as well as oxygen through a mask or nose tube. To figure
out the right spot to do the biopsy, your doctor may take an X-ray. Then he'll spray numbing medication into your throat.
You usually get this type of lung biopsy when cells can't be reached with a bronchoscopy. Your doctor places a needle
through your chest between two ribs to take a sample from the outer area of your lungs. You'll be awake and your skin will
be numbed, and you may get a sedative to relax. To find the best place to do the procedure, you'll get an ultrasound, CT
scan, or a special type of X-ray known as fluoroscopy.
You may also hear your doctor call this a video-assisted thoracoscopic surgery (VATS). It checks for problems on the outside
of your lungs. You'll get general anesthesia for this procedure, which means you won't be awake for it. Your doctor puts a
breathing tube down your throat and into your lungs and keeps tabs on your breathing, blood pressure, oxygen levels, and
heart rate. The doctor makes up to three small cuts on your chest between your ribs, then puts a thin, lighted tube with a
camera on the end and uses tiny tools to pull out some cells.
Your doctor will usually only suggest this type of biopsy when other methods can't get cell samples. As with a thoracoscopic
lung biopsy, you won't be awake for this procedure. Your surgeon makes a larger cut than in other methods, which may run
from your chest and under your arms to your back. That lets your doctor reach your lungs and remove the cells.
8. Describe the principles of chest radiography, computed tomography, magnetic resonance imaging and positron
emission tomography.
Case Objectives
Chest pain that is often worse with deep breathing, coughing, or laughing
Hoarseness
Loss of appetite
Shortness of breath
Infections such as bronchitis and pneumonia that don’t go away or keep coming back
Nervous system changes (such as headache, weakness or numbness of an arm or leg, dizziness, balance problems,
or seizures), from cancer spread to the brain
Yellowing of the skin and eyes (jaundice), from cancer spread to the liver
Swelling of lymph nodes (collection of immune system cells) such as those in the neck or above the collarbone
Tobacco smoke
Exposure to radon
Radon is a naturally occurring radioactive gas that results from the breakdown of uranium in soil and rocks. You can’t see,
taste, or smell it. According to the US Environmental Protection Agency (EPA), radon is the second leading cause of lung
cancer in this country, and is the leading cause among non-smokers.
Exposure to asbestos
People who work with asbestos (such as in mines, mills, textile plants, places where insulation is used, and shipyards) are
several times more likely to die of lung cancer. Lung cancer risk is much greater in workers exposed to asbestos who also
smoke. It’s not clear how much low-level or short-term exposure to asbestos might raise lung cancer risk. People exposed
to large amounts of asbestos also have a greater risk of developing mesothelioma, a type of cancer that starts in the pleura
(the lining surrounding the lungs). For more on this type of cancer, see Malignant Mesothelioma.
Other carcinogens (cancer-causing agents) found in some workplaces that can increase lung cancer risk include: Radioactive
ores such as uranium; Inhaled chemicals such as arsenic, beryllium, cadmium, silica, vinyl chloride, nickel compounds,
chromium compounds, coal products, mustard gas, and chloromethyl ethers; Diesel exhaust
Studies looking at the possible role of vitamin supplements in reducing lung cancer risk have had disappointing results. In
fact, 2 large studies found that smokers who took beta carotene supplements actually had an increased risk of lung cancer.
Air pollution
Smoking marijuana
E-cigarettes
E-cigarettes are a type of electronic nicotine delivery system. They do not contain any tobacco but the Food and Drug
Administration (FDA) classifies them as “tobacco” products.
Talc is a mineral that in its natural form may contain asbestos. Some studies have suggested that talc miners and people
who operate talc mills might have a higher risk of lung cancer and other respiratory diseases because of their exposure to
industrial grade talc. But other studies have not found an increase in lung cancer rate.
About 10% to 15% of all lung cancers are SCLC and it is sometimes called oat cell cancer. This type of lung cancer tends to
grow and spread faster than NSCLC. About 70% of people with SCLC will have cancer that has already spread at the time
they are diagnosed. Since this cancer grows quickly, it tends to respond well to chemotherapy and radiation therapy.
Unfortunately, for most people, the cancer will return at some point.
i. Adenocarcinoma
Adenocarcinomas start in the cells that would normally secrete substances such as mucus. This type of lung cancer occurs
mainly in current or former smokers, but it is also the most common type of lung cancer seen in non-smokers. It is more
common in women than in men, and it is more likely to occur in younger people than other types of lung cancer.
Adenocarcinoma is usually found in the outer parts of the lung and is more likely to be found before it has spread. People
with a type of adenocarcinoma called adenocarcinoma in situ (previously called bronchioloalveolar carcinoma) tend to have
a better outlook than those with other types of lung cancer.
Squamous cell carcinomas start in squamous cells, which are flat cells that line the inside of the airways in the lungs. They
are often linked to a history of smoking and tend to be found in the central part of the lungs, near a main airway
(bronchus).
Large cell carcinoma can appear in any part of the lung. It tends to grow and spread quickly, which can make it harder to
treat. A subtype of large cell carcinoma, known as large cell neuroendocrine carcinoma, is a fast-growing cancer that is very
similar to small cell lung cancer.
A few other subtypes of NSCLC, such as adenosquamous carcinoma and sarcomatoid carcinoma, are much less common.
Stage I: The cancer is located only in the lungs and has not spread to any lymph nodes.
Stage II: The cancer is in the lung and nearby lymph nodes.
Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest, also described as locally
advanced disease. Stage III has two subtypes:
o If the cancer has spread only to lymph nodes on the same side of the chest where the cancer started, it
is called stage IIIA.
o If the cancer has spread to the lymph nodes on the opposite side of the chest, or above the collar bone,
it is called stage IIIB.
Stage IV: This is the most advanced stage of lung cancer, and is also described as advanced disease. This is when
the cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body, such as
the liver or other organs.
Clinicians use a staging system for lung cancer called TNM, where:
M describes whether the cancer has spread to another area of the body such as the liver (metastasis)
T1 lung cancer means that the cancer is still inside the lung.
the tumour has spread into the main airway or the inner lining of the chest wall, or
the tumour has spread into the chest wall, the phrenic nerve (a nerve close to the lungs), or the outer layer of the
heart (pericardium)
the tumour has spread into both sections of the lung (each lung is made up of 2 sections, known as lobes), or
the tumour has spread into an area of the body near to the lung, such as the heart, the windpipe, the food pipe
(oesophagus) or a major blood vessel
N1 is used to describe cancerous cells in the lymph nodes located inside the lung or in the area where the lungs connect to
the airway (the hilum).
N2 is used to describe 2 possibilities:
there are cancerous cells in the lymph nodes located in the centre of the chest on the same side as the affected
lung, or
there are cancerous cells in the lymph nodes underneath the windpipe
there are cancerous cells in the lymph nodes located on the chest wall on the other side of the affected lung, or
there are cancerous cells in the lymph nodes above the collar bone, or
there are cancerous cells in the lymph nodes at the top of the lung
M0 – the cancer has not spread outside the lung to another part of the body
M1 – the cancer has spread outside the lung to another part of the body
SCLC
Chemotherapy
Chemotherapy improves the survival of patients with limited-stage disease (LD) or extensive-stage disease (ED), but it is
curative in only a minority of patients. Because patients with SCLC tend to develop distant metastases, localized forms of
treatment, such as surgical resection or radiation therapy, rarely produce long-term survival.
Radiation Therapy
SCLC is highly radiosensitive and thoracic radiation therapy improves survival of patients with LD and ED tumors.
NSCLC
Surgery
o Pneumonectomy: This surgery removes an entire lung. This might be needed if the tumor is close to the center of the
chest.
o Lobectomy: The lungs are made up of 5 lobes (3 on the right and 2 on the left). In this surgery, the entire lobe
containing the tumor(s) is removed. If it can be done, this is often the preferred type of operation for NSCLC.
o Segmentectomy or wedge resection: In these surgeries, only part of a lobe is removed. This approach might be used if
a person doesn’t have enough normal lung function to withstand removing the whole lobe.
o Sleeve resection: This operation may be used to treat some cancers in large airways in the lungs. If you think of the
large airway with a tumor as similar to the sleeve of a shirt with a stain a few inches above the wrist, the sleeve
resection would be like cutting across the sleeve (airway) above and below the stain (tumor) and then sewing the cuff
back onto the shortened sleeve.
Radiofrequency
Radiofrequency ablation (RFA) might be considered for some people with small lung tumors that are near the outer edge of
the lungs, especially if they can’t tolerate surgery. RFA uses high-energy radio waves to heat the tumor. A thin, needle-like
probe is put through the skin and moved in until the tip is in the tumor. Placement of the probe is guided by CT scans. Once
the tip is in place, an electric current is passed through the probe, which heats the tumor and destroys the cancer cells.
Radiation
External beam radiation therapy (EBRT) focuses radiation from outside the body onto the cancer. This is the type of
radiation therapy most often used to treat NSCLC or its spread to other organs.
In people with NSCLC, brachytherapy is sometimes used to shrink tumors in the airway to relieve symptoms. The doctor
places a small source of radioactive material (often in the form of small pellets) directly into the cancer or into the airway
next to the cancer.
Chemotherapy
Cisplatin, Carboplatin, Paclitaxel (Taxol), Albumin-bound paclitaxel (nab-paclitaxel, Abraxane), Docetaxel (Taxotere),
Gemcitabine (Gemzar), Vinorelbine (Navelbine), Etoposide (VP-16), Pemetrexed (Alimta).
Targeted therapy
Immunotherapy
Nivolumab (Opdivo) and pembrolizumab (Keytruda) target PD-1, a protein on certain immune cells (called T cells) that
normally helps keep these cells from attacking other cells in the body. By blocking PD-1, these drugs boost the immune
response against cancer cells. This can shrink some tumors or slow their growth.
Atezolizumab (Tecentriq) targets PD-L1, a protein related to PD-1 that is found on some tumor cells and immune cells.
Blocking this protein can also help boost the immune response against cancer cells.
Palliative therapy